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今  川  章  夫
CLINICAL STUDIES OF HEMOFILTRATION
一3一 IMMUNITY
           Akio IMAGAwA’
From the Urological Clinic， Takamdtsu Red Cross HosPital， Kagawa， JaPan
  Eight patients of renal insufliciency were treated by hemofiltration （HF） for a period of three
months， and the fluctuations of immunity were studied． The following results were’obtained：
1） No change was noted in serum immune globulin．
2） Complement protein volume C3c dropped remarkably in the three－month period， while C4 did
 not change．
3） Peripheral bloed IYmphocyte count and T cell count notably increased to ． a normal level after
 three months of treatment， but the B cell count did not change．
4） The PHA skin test shewed sighificantly increased reaction in three months． As for the PPD skin
 test， four cases of negative results turned Positive at the end of the treating peariod．
  Hence， it may be concluded that HF is effective for normalization of cellular immuni．ty， and it
is assumed that the excellent removability of middle molecular weight substance of HF has greatly
contributed to this result． Meanwhile， it is concluded that HF may be effectively applied to cases
of renal insuMciency with marked drop of cellular immunity．
        緒     言
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人の平均値はIgG l407．0±513．62 mg／d1， IgA 302．8」＝
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Fig． 2． Changes of serum complement protein levels in patients undergoing hemofiltration
今川：Hemofiltration・免疫機能
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